334results about "Mammary implants" patented technology

The present disclosure provides alert implants that comprise a medical device and an implantable reporting processor (IRP), where one example of such a medical device includes a component for a total knee arthroplasty (TKA) such as a tibial extension, a femoral component for hip replacements, a breast implant, a distal rod for arm or leg breakage repair, a scoliosis rod, a dynamic hip screw, a spinal interbody spacer, and tooling and methods that may be used to form the alert implant, and uses of such alert implants in the health maintenance of patients who receive the implant.

Embodiments described herein relate to a support device configured to provide tissue support, during implant-based breast surgery. Embodiments described herein include a matrix sheet disposed in a foldable sheet including one or more templates including at least one of a partial support template and a full support template. The partial support template is configured for use in shaping the matrix sheet into a support device for partial coverage for a breast prosthesis. The full support template is configured for use in shaping the matrix sheet into a support device for full coverage for a breast prosthesis. In some embodiments, the support device is a bioabsorbable mesh substrate, a bioabsorbable polymer coating, and one or more active pharmaceutical agents for delivery at the surgical site. The support device may be provided in various shapes for coverage of the breast prosthesis or provided with templates for various coverage of the breast prosthesis. The support device forms a macroporous scaffold, and the macroporous scaffold may act as a lattice for new tissue ingrowth.

Implantable transponders comprising no ferromagnetic parts for use in medical implants are disclosed herein. Such transponders may assist in preventing interference of transponders with medical imaging technologies. Such transponders may optionally be of a small size, and may assist in collecting and transmitting data and information regarding implanted medical devices. Methods of using such transponders, readers for detecting such transponders, and methods for using such readers are also described.

Various implementations include a breast tissue expander device. The device includes one or more tabs extending outwardly from a body of the device for coupling the device to the chest wall of a patient. The device further includes an aspiration port in fluid communication with a drain tube for draining body fluid, along with retention members for securing the drain tube to the body. The device may also include one or more flow barriers configured to prevent the inadvertent leakage of expansion fluid or body fluid from the device.

Embodiments described herein relate to a support device configured to provide tissue support, during implant-based breast surgery. Embodiments described herein include a matrix sheet disposed in a foldable sheet including one or more templates including at least one of a partial support template and a full support template. The partial support template is configured for use in shaping the matrix sheet into a support device for partial coverage for a breast prosthesis. The full support template is configured for use in shaping the matrix sheet into a support device for full coverage for a breast prosthesis. In some embodiments, the support device is a bioabsorbable mesh substrate, a bioabsorbable polymer coating, and one or more active pharmaceutical agents for delivery at the surgical site. The support device may be provided in various shapes for coverage of the breast prosthesis or provided with templates for various coverage of the breast prosthesis. The support device forms a macroporous scaffold, and the macroporous scaffold may act as a lattice for new tissue ingrowth.

An operable implant adapted for implantation into a patient's body. The operable implant comprises an operating device and a body-engaging portion, the operating device comprising an electric motor including a stationary part containing a plurality of coils and a movable part containing a plurality of magnets, such that sequential energization of the coils magnetically propels the magnets and, thereby, the movable part. The operating device further comprises an encapsulation adapted to hermetically encapsulate the coils of the stationary part, thereby forming a seal between the stationary part and the movable part, which is propelled by the contained magnets, such that the coils of the stationary part are sealed from bodily fluids when implanted.

A method for fabricating a pacifier having surface features replicating those of a nursing mother's nipple, wherein the nipple has a length, the method including steps of utilizing the nursing mother's nipple as a positive mold to cast a first negative mold; utilizing the first negative mold to cast a replica of the nursing mother's nipple; modifying the replica of the nursing mother's nipple so that said replica has a length greater than that of the nursing mother's nipple; utilizing the modified replica of the nursing mother's nipple as a second positive mold to cast a second negative mold; and utilizing the second negative mold to cast an extended length replica of the nursing mother's nipple.

This application relates to a breast implant and an apparatus for sensing an abnormality of the breast implant. In one aspect, the breast implant includes a shell including an injection hole and forming an outer cover of the breast implant and a filler of a gel state injected into the shell through the injection hole. The breast implant may also include a first patch configured to seal the injection hole, the first patch including a first sensor module. The breast implant may further include a second patch configured to be attached on at least one of a second position facing the first position and a third position to which a pressure due to a gravity is applied when the breast implant is inserted in a breast and a body is kept upright without an external pressure applied, the second patch including a second sensor module.

Implantable prostheses and related methods are generally described. In some embodiments, the prosthesis may be used for soft tissue reconstruction. The prosthesis may be formed from a three-dimensional load-bearing porous scaffold having interconnected networks of pores, thereby enabling tissue infiltration and allowing native tissue, blood vessels, and cells to colonize on the scaffold. In some embodiments, the scaffold may be formed from a biodegradable material such that it may degrade during the tissue infiltration process, leaving native tissue. In some embodiments, the stent may be formed from a triple periodic minimum surface, such as a helical tetracosahedron, to achieve high compressibility and high porosity. The compressibility of the implant may simulate the mechanical behavior of native tissue and allow the implant to be delivered through a small incision site (e.g., with an implant delivery funnel).

The invention pertains to an external breast prosthesis (12) comprising a main body made from a polymer, the body having an inner surface (13) for coinciding with an outer chest surface of a person wearing the breast prosthesis and an opposing outer surface (14), wherein the main body comprises multiple elongated thermal conductors (15) that extend from a position adjacent the inner surface of the breast prosthesis to a position adjacent the outer surface of the breast prosthesis.

A surgical implant delivery device is provided. The surgical implant delivery device comprises a sleeve. The sleeve includes a delivery portion and an accommodating portion. The delivery portion has an opening. The accommodating portion extending from the delivery portion. The delivery portion includes a wing portion protruding widthwise. The wing portion is foldable to reduce the width of the opening.

The present disclosure relates to novel pharmaceutical compositions and their use in general tissue reconstructive and augmentative methods. The pharmaceutical compositions comprise multilayered acellular matrices, such as dermal matrices (ADMs), of two or more layers. The compositions may be used in any general tissue reconstructive or augmentative medical procedure where the goal is to increase the volume in the area of the body in which the multilayered ADM compositions are introduced.

The invention is a pharmaceutical device (1) for use with animals, comprising a body (10) made of one or more solid metals selected from those on which ions have a biocidal effect. The body (10) comprises an inner porous matrix (11) having a porosity of at least 1%, from which biocidal metal ions can be released, and an outer surface of the body (10) is configured to be located at a treatment site (20) of the animal (2).

To provide a tissue product, more specifically, an extracellular tissue matrix made from adipose tissue.SOLUTION: A tissue product is provided, wherein the tissue product comprises a breast implant in the form of a porous acellular tissue matrix sponge, wherein the implant comprises an acellular adipose tissue matrix construct comprising a particulate acellular adipose tissue matrix, wherein the matrix is in a suspended, dried and stabilized form, and wherein the suspension comprises 2-10 wt.% solids.SELECTED DRAWING: None

The present invention relates to a bioresorbable implantable device comprising a base structure comprising at least one base layer (10) comprising: • - an assembly A (1A) comprising a layer of a plurality of elongate elements A1 (1A1) which are oriented in a longitudinal direction LA1, and a layer of a plurality of elongate elements A2 (1A2); an assembly B (1B) comprising a layer of a plurality of elongate elements B1 (1B1) which are oriented in a longitudinal direction LB1, and a layer of a plurality of elongate elements B2 (1B2); • - the assembly B (1B) is placed at least partially on top of the assembly A (1A); • - the direction LA1 intersects the direction LB1; and • - the base structure comprises a plurality of base layers placed at least partially one on top of the other.

The present disclosure provides devices, systems, and methods relating to performing a medical procedure. In particular, the present disclosure is directed to devices, systems, and methods for positioning and securing a body implant in a subject in a manner that is customizable for each subject and minimizes implant migration. The devices, systems, and methods described herein utilize biocompatible and biodegradable materials that provide enhanced long-term fixation of the implant.

To provide an external breast prosthesis that has improved drying properties, weight, or ease of adjustment. [Solution] The external artificial breast 1 comprises a breast body 10 having a first layer 11 positioned on the user 91 side and a second layer 12 positioned on the opposite side of the first layer, the first layer and the second layer being joined to each other at their periphery, and a bag-shaped space 15 with an opening 13 being formed between the first layer and the second layer, and an adjustment member 20 that is detachably housed in the space through the opening to adjust the thickness of the breast body. At least the first layer of the breast body is made of wetsuit material.

Implantable prostheses and related methods are generally described. In some embodiments, the prosthesis (100) may be a generally ellipsoidal (e.g., spherical) shape, formed of one or more subunits (20). The subunits may be conical or frustoconical, formed through manipulation of a two-dimensional substrate material. The sidewalls of the subunits may be fixed to one another to enhance the stiffness of the prosthesis. In some embodiments, markers (30) may be used to help distinguish the prosthesis in the implant site through medical imaging modalities (e.g., x-ray imaging). In this way, the implant site, which may also be the site of a recent biopsy and / or a diseased tissue resection, may readily be identified. The prosthesis may be formed of a porous material to induce tissue infiltration, which may facilitate natural tissue regeneration for more natural look and feel of the tissue. Tissue infiltration may result in the prosthesis having an enhanced resistance to migration following implantation.

Disclosed are a tissue expander for breast reconstruction comprising an MMP sensor and thus being capable of real-time capsular contracture monitoring and treatment, and a patient information system linked thereto. According to these, a patient or medical staff can easily check and evaluate capsular contracture, which may occur when wearing a tissue expander for breast reconstruction, and whether inflammation, a side effect, or the like is caused thereby, even outside the human body in real time. Accordingly, before or when capsular contracture occurs, effective treatment and response are possible.

This invention provides tissue products manufactured from adipose tissue and methods for manufacturing the same. [Solution] A method for producing a tissue product is provided, comprising the steps of: selecting adipose tissue; processing the tissue to remove substantially all cellular material from the tissue; suspending the tissue in a liquid to form a suspension containing 2-4% by weight of solids; and freezing and drying the suspension to form a porous sponge.

Resorbable multifilament yarns and monofilament fibers including poly-4-hydroxybutyrate and copolymers thereof with high tenacity or high tensile strength have been developed. The yarns and fibers are produced by cold drawing the multifilament yarns and monofilament fibers before hot drawing the yarns and fibers under tension at temperatures above the melt temperature of the polymer or copolymer. These yarns and fibers have prolonged strength retention in vivo making them suitable for soft tissue repairs where high strength and strength retention is required. The multifilament yarns have tenacities higher than 8.1 grams per denier, and in vivo, retain at least 65% of their initial strength at 2 weeks. The monofilament fibers retain at least 50% of their initial strength at 4 weeks in vivo. The monofilament fibers have tensile strengths higher than 500 MPa. These yarns and fibers may be used to make various medical devices for various applications.

In a method of applying a desired texture to a surface of a silicone elastomer, an uncured silicone elastomer is applied to at least one side of a polymeric film. At least one side of the polymeric film has a complementary texture that is complementary in shape to the desired texture. The uncured silicone elastomer is cured while it is in contact with the at least one side of the polymeric film so as to form a cured silicone elastomer. The polymeric film is removed from the cured silicone elastomer so as to expose the desired texture on the surface thereof. The flexible polymeric film can be a bag placed into a breast prosthesis mold. The bag includes at least one interior surface with the complementary texture. The bag is removed from the cured silicone elastomer to expose the breast prosthesis having a textured surface.

A universal biological prosthesis of acellular dermal matrix (ADM) intended for use in body reconstruction processes and method of manufacture. A universal biological prosthesis of acellular dermal matrix (ADM) intended for use in body reconstruction processes, comprising: a first layer of ADM of biological origin arranged inferiorly to delimit a cavity with a lower edge; a filling material disposed in the cavity surrounded by the first layer of ADM consisting of a ground ADM having the consistency of a fibrous paste; and a second layer of ADM of biological origin arranged on the upper part covering the filling material and whose upper edge rests peripherally on the lower edge of the first layer of ADM, thus defining a rim;where the first layer of ADM and the second layer of ADM are joined by an eyebrow overlap along the upper edge of the first layer of ADM with the lower edge of the peripheral rim using a biocompatible adhesive, or by absorbable suture; where the first layer of ADM, the second layer of ADM and the ADM filling material are not immunogenic; and where the ADM comprises collagen fibers, fibronectin, elastin, laminin, glycosaminoglycans and hyaluronic acid. Method for its manufacture.

The present invention relates to a breast prosthesis. More specifically, it is a breast prosthesis for external use. The breast prosthesis (10) comprises a lattice structure (12) made from a network of filaments (14).

Particular embodiments herein relate to an implant for insertion into a patient for soft tissue reconstruction. The implant (200) comprises a plurality of unit cells (102) arranged to form a three-dimensional grid structure, the three-dimensional structure having an idle volume of the implant. The plurality of unit cells are arranged to form a porous network of a three-dimensional structure (101) wherein the three-dimensional structure is a reversibly compressible three-dimensional structure, and wherein the overall porosity of the three-dimensional structure of the implant is at least 50%.

Resorbable implants comprising poly(butylene succinate) and copolymers thereof have been developed. The implants implants are preferably sterilized, and contain less than 20 endotoxin units per device as determined by the limulus amebocyte lysate (LAL) assay, and are particularly suitable for use in procedures where prolonged strength retention is necessary, and can include one or more bioactive agents. The implants may be made from fibers and meshes of poly(butylene succinate) and copolymers thereof, or by 3d printing, and the fibers may be oriented. Coverings and receptacles made from forms of poly(butylene succinate) and copolymers thereof have also been developed for use with cardiac rhythm management devices and other implantable devices. These coverings and receptacles may be used to hold, or partially / fully cover, devices such as pacemakers and neurostimulators. The coverings and receptacles are made from meshes, webs, lattices, non-wovens, films, fibers, and foams, and contain antibiotics such as rifampin and minocycline.

The disclosed composite scaffold provides a highly porous and flexible structure that substantially maintains its three-dimensional shape under tension and provides mechanical reinforcement of the repair or reconstruction-first via scaffold mechanical properties, and subsequently, through newly regenerated functional tissue as the scaffold is resorbed.

Absorbable implants for breast surgery that conform to the breast parenchyma and surrounding chest wall have been developed. These implants support newly lifted breast parenchyma, and / or a breast implant. The implants have mechanical properties sufficient to support a reconstructed breast, and allow the in-growth of tissue into the implant as it degrades. The implants have a strength retention profile allowing the support of the breast to be transitioned from the implant to regenerated host tissue, without significant loss of support. Three-dimensional implants for use in minimally invasive mastopexy / breast reconstruction procedures are also described, that confer shape to a patient's breast. These implants are self-reinforced, can be temporarily deformed, implanted in a suitably dissected tissue plane, and resume their preformed three-dimensional shape. The implants are preferably made from poly-4-hydroxybutyrate (P4HB) and copolymers thereof. The implants have suture pullout strengths that can resist the mechanical loads exerted on the reconstructed breast.